Supriya Lifescience Ltd share price logo

Supriya Lifescience Ltd

NSE: SUPRIYA

BSE: 543434

Small Cap

Pharma Sector

₹690.75

-0.45

(-0.07%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Supriya Lifescience Stock Performance

as on May 5, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹681.35
    ₹695.00
    downward going graph

    1.36%

    Downside

    0.62%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹545.50
    ₹832.40
    downward going graph

    21.03%

    Downside

    20.51%

    Upside

    downward going graph

Supriya Lifescience share price movements today

Previous Close
₹691.20
Open
₹690.00
Volume
94.79K
Upper Circuit
₹829.40
Lower Circuit
₹553.00
Day's Low - High
₹681.35 - ₹695.00
52 Week Low - High
₹545.50 - ₹832.40

Supriya Lifescience Historical Returns

1 Month Return
+ 12.22 %
3 Month Return
+ 3.21 %
1 Year Return
+ 10.19 %
3 Year Return
+ 211.57 %
5 Year Return
+ 76.73 %

Supriya Lifescience Fundamentals

as on May 5, 2026 at 4:01 pm IST

Market Cap

₹5,559.35 Cr

Return on Equity (ROE)

20.74

PE Ratio (TTM)

0

Return on capital employed (ROCE)

27.43

Beta (LTM)

1.14

P/B Ratio

5.92

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

6.2

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Supriya Lifescience Technical Analysis

Track how Supriya Lifescience technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish
Bullish12
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.32
Bullish
CCI (20)
-33.3
Neutral
RSI (14)
62.85
Neutral
Momentum (10)
0.45
Bullish
ADI (14)
19.96
Neutral
Ultimate Oscillator (7,14,28)
74.18
Bullish

Moving Averages

Name

Value

Action

SMA (20)
690.02
Bullish
EMA (20)
690.05
Bullish
VWMA (20)
690.24
Bullish
SMA (50)
689.5
Bullish
EMA (50)
689.66
Bullish
SMA (200)
689.32
Bullish
EMA (200)
689.17
Bullish
KAMA (200)
689.44
Bullish
DEMA (200)
689.34
Bullish

Supriya Lifescience Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Supriya Lifescience with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Supriya Lifescience Ltd image
Supriya Lifescience Ltd
BUY5,559.3515.35%0.00187696
Pfizer Ltd image
Pfizer Ltd
BUY21,492.28-2.36%0.00NANA
Kwality Pharmaceuticals Ltd image
Kwality Pharmaceuticals Ltd
NA1,726.81300.5%0.6539370
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,402.091314.17%0.00932
Wockhardt Ltd image
Wockhardt Ltd
NA24,975.0536.73%0.68-573,012
See all

Market expectation of Supriya Lifescience Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Supriya Lifescience Stock’s Investor Sentiment and Interest

Search interest for Supriya Lifescience Ltd Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:51% versus previous 30 day period

Supriya Lifescience Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
132.02
140.1
140.07
158.18
160.63
166.1
185.65
184.11
145.07
199.83
206.44
Other Income
2.92
2.47
3.07
2.19
2.22
2.52
2.1
2.98
2.67
2.73
2.61
Total Income
134.94
142.56
143.14
160.37
162.85
168.62
187.75
187.08
147.75
202.56
209.05
Expenses
87.79
108.34
98.59
102.68
98.09
101.39
119.7
116.53
93.37
127.19
134.82
Operating Profit
44.23
31.76
41.48
55.5
62.54
64.71
65.95
67.58
51.7
72.64
71.62
Operating Profit Margin %
33.5%
22.67%
29.61%
35.09%
38.93%
38.96%
35.52%
36.71%
35.64%
36.35%
34.69%
Profit Before Interest, Tax and Depreciation
47.15
34.22
44.55
57.69
64.77
67.24
68.05
70.56
54.38
75.37
74.24
Interest
0.56
0.46
0.49
0.6
0.34
0.43
0.51
0.42
0.51
0.42
0.49
Depreciation
3.96
3.98
3.96
3.91
4.66
4.74
4.96
6.08
6.45
6.64
6.82
Profit Before Tax
42.63
29.78
40.1
53.18
59.77
62.07
62.58
64.06
47.42
68.31
66.93
Tax Paid
14.12
5.9
10.32
16.24
15.13
15.92
15.8
13.68
12.63
17.89
17.24
Profit After Tax
28.51
23.88
29.79
36.93
44.64
46.15
46.78
50.38
34.79
50.43
49.68
Total Net profit including share of profit / Loss from associate company
28.51
23.88
29.79
36.93
44.64
46.15
46.78
50.38
34.79
50.43
49.68
EPS
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27
6.17
Actual EPS
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27
6.17
Adjusted EPS
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27
6.17
Diluted EPS
3.54
2.97
3.7
4.59
5.54
5.71
5.82
6.29
4.32
6.27
6.17

Supriya Lifescience Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
212.91
277.84
311.64
391.25
530.05
460.94
570.37
696.49
Other Income
8.6
8.02
11.07
4.98
7.58
9.49
10.64
9.82
Total Income
221.51
285.86
322.71
396.22
537.63
470.43
581.01
706.3
Expenses
190.96
213.1
213.26
218.07
316.06
332.04
397.39
435.69
Operating Profit
21.95
64.74
98.38
173.18
213.99
128.9
172.98
260.8
Operating Profit Margin %
10.31%
23.3%
31.57%
44.26%
40.37%
27.96%
30.33%
37.44%
Profit Before Interest, Tax and Depreciation
30.55
72.76
109.45
178.15
221.56
138.39
183.61
270.61
Interest
10.75
10.22
6.85
4.08
4.2
3.08
2.11
1.69
Depreciation
5.33
5.44
6.41
6.76
10.12
11.82
15.81
20.44
Profit Before Tax
14.47
57.1
96.19
167.31
207.24
123.49
165.69
248.48
Tax Paid
5.74
17.68
22.82
43.72
55.44
33.63
46.58
60.53
Profit After Tax
8.73
39.42
73.37
123.59
151.81
89.86
119.11
187.96
Total Net profit including share of profit / Loss from associate company
8.73
39.42
73.37
123.59
151.81
89.86
119.11
187.96
EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35
Actual EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35
Adjusted EPS
1.19
5.39
2.01
16.89
18.86
11.16
14.8
23.35
Diluted EPS
1.19
5.39
10.03
16.89
18.86
11.16
14.8
23.35

Supriya Lifescience Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
13.5
27.34
27.76
48.88
116.67
75.89
48.8
63.61
113.31
164.68
Cash Flow from Investing Activities
-32.83
-8.57
-4.71
4.83
-25.14
-46.8
-59.82
-123.65
-173.57
-152.24
Cash Flow from Financing Activities
21.36
-2.25
-20.01
-49.92
-29.24
-14.51
149.65
-10.28
-22.36
-8.24
Net Cash Flow
2.03
-1.51
3.03
3.79
62.31
14.57
138.63
-70.33
-82.63
4.2

Supriya Lifescience Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
68.3%
DII
7.55%
7.17%
3.85%
5.3%
5.48%
5.45%
4.92%
4.26%
4.86%
5.22%
5.01%
5.7%
FII
0%
5.34%
0%
5.36%
4.95%
6.03%
6.52%
7.19%
6.78%
5.46%
5.2%
5.16%
Public
18.43%
19.19%
21.76%
21.04%
21.27%
20.23%
20.26%
20.26%
20.06%
21.02%
21.5%
20.84%
Total Outstanding Shares
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
8,04,82,800
Total Shareholders
93,478
92,991
95,929
87,980
89,621
85,328
89,394
91,051
91,928
87,912
85,099
81,161

Mutual Funds that own Supriya Lifescience Stock

Check out the Mutual Funds with significant holdings in Supriya Lifescience.

Supriya Lifescience Corporate Actions

View detailed summary of the earnings and dividend history of Supriya Lifescience.

  • Supriya Lifescience Ltd Earnings Results

    Supriya Lifescience Ltd’s net profit jumped 6.2% since last year same period to ₹49.68Cr in the Q3 2025-2026. On a quarterly growth basis, Supriya Lifescience Ltd has generated -1.49% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Supriya Lifescience Ltd Dividends May,2025

    In the quarter ending March 2025, Supriya Lifescience Ltd has declared dividend of ₹1.00 per share on 27 May 2025 - translating a dividend yield of 0.26%.

    Read More about Dividends

Indices Featuring Supriya Lifescience Stock

Check stock indices that include Supriya Lifescience.

BSE Healthcare

₹45,327.00

0.13 (▲57.98%)

Insights on Supriya Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.67% to 1.33% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SUPRIYA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, SUPRIYA stock has moved up by 212.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 29.4% return, outperforming this stock by 24.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.30% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.50% to 20.84% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 5.20% to 5.16% in Mar 2026 quarter

About Supriya Lifescience Ltd

Supriya Lifescience Limited is an Indian manufacturing company and supplier of active pharmaceutical ingredients (APIs). As of 31 March 2021, the company has offered 39 APIs with a focus on therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatics and anti-allergies. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India - 4555 and 6570 units, respectively - between Fiscal 2017 and 2020. Supriya Lifescience has sought approval for its products from international regulatory authorities including the USFDA, EUGMP and EDQM, and is supported by a modern manufacturing facility. Two new clean rooms are set to be powered up in the first quarter of Fiscal 2022. Over the years, the company has issued 3002400, 1626302, 9757804 Equity shares and increased its face value from Rs 10 to Rs 2 per share. In December 2021, Supriya Lifescience Limited conducted a Rs 700 crores public issue and the allotted shares were listed on BSE Ltd and NSE.

Revenue: ₹206.44Cr as on December 2025 (Q3 FY26)
Net Profit: ₹49.68Cr as on December 2025 (Q3 FY26)
Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh
OrganisationSupriya Lifescience Ltd
IndustryPharmaceuticals
CEOSatish Waman Wagh
E-voting on sharesClick here to vote

FAQs

What is Supriya Lifescience share price today?

Supriya Lifescience share price today stands at ₹690.75 as on at the close of the market. Supriya Lifescience share today touched a day high of ₹695 and a low of ₹681.35.

What is the 52 week high and 52 week low range for Supriya Lifescience share?

Supriya Lifescience touched a 52 week high of ₹832.4 and a 52 week low of ₹545.5. Supriya Lifescience share price today i.e. is closed at ₹690.75, which is -17.02% down from its 52 week high and 26.63% up from its 52 week low.

What is Supriya Lifescience's market capitalisation today?

Supriya Lifescience market capitalisation is ₹5,559.35 Cr as on .

How to buy Supriya Lifescience shares?

To buy Supriya Lifescience shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUPRIYA or Supriya Lifescience Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Supriya Lifescience shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Supriya Lifescience trading volume today?

Supriya Lifescience trading volume is 94.79K as on . This means that 94.79K shares of Supriya Lifescience were bought and sold on the stock market during today's trading session.